Analystreport

Fibrocell Science Inc (NASDAQ: FCSC) had its "buy" rating re-affirmed by analysts at HC Wainwright.

FIBROCELL SCIENCE INC COMMON  (FCSC) 
NASDAQ:AMEX Investor Relations: fibrocell.com